THE EFFECT OF PH AND TEMPERATURE ON THE SELF-ASSOCIATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AS STUDIED BY EQUILIBRIUM SEDIMENTATION

被引:8
|
作者
ADVANT, SJ
BRASWELL, EH
KUMAR, CV
KALONIA, DS
机构
[1] UNIV CONNECTICUT, DEPT PHARMACEUT SCI, STORRS, CT 06269 USA
[2] UNIV CONNECTICUT, DEPT MOLEC & CELL BIOL, STORRS, CT 06269 USA
[3] UNIV CONNECTICUT, NATL ANALYT ULTRACENTRIFUGAT FACIL, STORRS, CT 06269 USA
[4] UNIV CONNECTICUT, DEPT CHEM, STORRS, CT 06269 USA
关键词
INTERLEUKIN-2; SELF-ASSOCIATION; AGGREGATION; ANALYTICAL ULTRACENTRIFUGE;
D O I
10.1023/A:1016286920643
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The self-association of recombinant human interleukin-2 (rhIL-2) in solution was investigated as a function of pH and temperature using equilibrium sedimentation. Studies were performed at pH 3.6, 6.5 and 8.2, at 1 degrees C and 20 degrees C. A model assuming an ideal single molecular species describes the data observed at pH 6.5 at both temperatures. At pH 8.2, the data from both temperatures can be better described by a weak monomer-dimer association equilibrium. The values of the association constants obtained indicate the presence of less than 10% dimer at a concentration of 1 mg/ml at both temperatures. At pH 3.6, aggregates with a Z average molecular weight of over 35 times that of monomeric rhIL-2 were formed. The smallest associating species present under these conditions corresponds to the monomer, which produces aggregates with a wide range of molecular weights. The monomer appears to be in equilibrium with the smallest aggregates, in that a model describing an indefinite association fits the data obtained at the highest centrifugal speed. No model was found to successfully describe the association of the monomer into the much larger aggregates observed at lower speeds. This may be the result of the lack of rapid thermodynamic reversibility of the larger aggregates. Temperature was found to have no significant effect on the largest aggregates that were formed at pH 3.6.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 50 条
  • [21] INCREASED PROLIFERATION OF A HUMAN BREAST-CARCINOMA CELL-LINE BY RECOMBINANT INTERLEUKIN-2
    KATANO, M
    MATSUO, T
    MORISAKI, T
    NAITO, K
    NAGUMO, F
    KUBOTA, E
    NAKAMURA, M
    HISATSUGU, T
    TADANO, J
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (03) : 161 - 166
  • [22] PHASE-I TRIAL OF A RECOMBINANT HUMAN INTERLEUKIN-2 IN PATIENTS WITH DISSEMINATED SOLID TUMORS
    TURSZ, T
    DORVAL, T
    BERTHAUD, P
    JOUVE, M
    AVRIL, MF
    GARCIAGIRALT, E
    LECHEVALIER, T
    SPIELMANN, M
    SEVIN, D
    PALANGIE, T
    BRANDELY, M
    FRIDMAN, WH
    HERCEND, T
    POUILLART, P
    PRESSE MEDICALE, 1991, 20 (06): : 250 - 254
  • [23] EFFECT OF HUMAN, RECOMBINANT INTERLEUKIN-2 ON PUNTA TORO VIRUS-INFECTIONS IN C57BL/6 MICE
    MEAD, JR
    BURGER, RA
    YONK, LJ
    COOMBS, J
    WARREN, RP
    KENDE, M
    HUGGINS, J
    SIDWELL, RW
    ANTIVIRAL RESEARCH, 1991, 15 (04) : 331 - 340
  • [24] Extracellular pH affects the proliferation of cultured human T cells and their expression of the interleukin-2 receptor
    Carswell, KS
    Papoutsakis, ET
    JOURNAL OF IMMUNOTHERAPY, 2000, 23 (06): : 669 - 674
  • [25] RECOMBINANT INTERLEUKIN-2 TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - EFFECT ON NATURAL CYTOTOXICITY
    PARK, KGM
    HEYS, SD
    MURRAY, JB
    HAYES, PD
    ASHBY, JA
    FRANKS, CR
    EREMIN, O
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1992, 35 (01) : 53 - 58
  • [26] In Vitro Assessment of Choline Dihydrogen Phosphate (CDHP) as a Vehicle for Recombinant Human Interleukin-2 (rhIL-2)
    Foureau, David M.
    Vrikkis, Regina M.
    Jones, Chase P.
    Weaver, Katherine D.
    MacFarlane, Douglas R.
    Salo, Jonathan C.
    McKillop, Iain H.
    Elliott, Gloria D.
    CELLULAR AND MOLECULAR BIOENGINEERING, 2012, 5 (04) : 390 - 401
  • [27] In Vitro Assessment of Choline Dihydrogen Phosphate (CDHP) as a Vehicle for Recombinant Human Interleukin-2 (rhIL-2)
    David M. Foureau
    Regina M. Vrikkis
    Chase P. Jones
    Katherine D. Weaver
    Douglas R. MacFarlane
    Jonathan C. Salo
    Iain H. McKillop
    Gloria D. Elliott
    Cellular and Molecular Bioengineering, 2012, 5 : 390 - 401
  • [28] ANTITUMOR EFFECTS OF POLYETHYLENE GLYCOLMODIFIED RECOMBINANT HUMAN INTERLEUKIN-2 ON MOUSE UTERINE CERVICAL CARCINOMA IN VIVO
    王立夫
    吴裕炘
    章永平
    唐微
    刘新垣
    Chinese Journal of Cancer Research, 1997, (01) : 28 - 31
  • [29] Pharmacokinetics of recombinant human interleukin-2 in advanced renal cell carcinoma patients following subcutaneous application
    Kirchner, GI
    Franzke, A
    Buer, J
    Beil, W
    Probst-Kepper, M
    Wittke, F
    Övermann, K
    Lassmann, S
    Hoffmann, R
    Kirchner, H
    Ganser, A
    Atzpodien, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (01) : 5 - 10
  • [30] CLINICAL AND IMMUNOLOGICAL EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-2 GIVEN BY REPETITIVE WEEKLY INFUSION TO NORMAL DOGS
    HELFAND, SC
    SOERGEL, SA
    MACWILLIAMS, PS
    HANK, JA
    SONDEL, PM
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (02) : 84 - 92